News
-
-
PRESS RELEASE
Ebenbuild publishes validation study in Nature Communications Medicine demonstrating strong predictive performance of lung digital twins
Ebenbuild publishes validation study in Nature Communications Medicine demonstrating strong predictive performance of lung digital twins. Study validates drug deposition prediction in human lungs -
-
PRESS RELEASE
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies
OBI Pharma showcases advancements in ADC technology at AACR 2026, highlighting GlycOBI platform. Poster presentations feature OBI-902, OBI-904, OBI-201, OBI-221, and novel Obrion technology -
-
-
-
-
-